PIC3CA, 5 or 11 mutations
Clinical Genetic Test
Help
offered by
GTR Test Accession: Help GTR000592350.1
CANCERBREAST DISORDERSRESPIRATORY DISEASE ... View more
Last updated in GTR: 2021-01-18
Last annual review date for the lab: 2022-11-21 Past due LinkOut
At a Glance
Drug Response; Mutation Confirmation; Pre-symptomatic; ...
Breast neoplasm; Non-small cell lung carcinoma
Genes (1): Help
PIK3CA (3q26.32)
Molecular Genetics - Targeted variant analysis: Quantitative PCR (qPCR)
Not provided
Not provided
Not provided
Ordering Information
Offered by: Help
GENOTYPOS MSA
Specimen Source: Help
Who can order: Help
  • Health Care Provider
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 2
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 1
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Targeted variant analysis
Quantitative PCR (qPCR)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Drug Response; Mutation Confirmation; Pre-symptomatic; Predictive; Prognostic; Risk Assessment; Screening; Therapeutic management
Recommended fields not provided:
Technical Information
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
LOD: 1 percent of mutant alleles
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Intra-Laboratory
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.